The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Dr. Brian Nussenbaum on the Difficulties of Improving Survival in Larynx Cancer

Brian Nussenbaum, MD, FACS
Published Online:2:42 PM, Thu February 25, 2016

Brian Nussenbaum, MD, FACS, Division Chief, Head and Neck Surgical Oncology, Department of Otolaryngology Head and Neck Surgery, Washington University, discusses trying to improve survival larynx cancer. Nussenbaum says the current balance in the treatment paradigm of larynx cancer is between surreal and cure, all while maintaining a functional preservation for the patient.

Nussenbaum says the current survival curve used in clinical trials does not lend itself toward powering treatments in the direction of giving patients a better rate of survival. He adds that despite these facts, the treatment paradigm in larynx cancer has moved itself enough to where a laryngectomy is normally avoidable, should it not be the best course of action for a patient.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.